Some GLP-1 receptor agonists, like Tirzepatide, have been shown to reduce the risk of major cardiovascular events (e.g., heart attack, stroke) in people with Type 2 diabetes and existing heart disease
The primary endpoints were the change in body weight and the proportions of patients losing at least 5% and 10% of their initial body weight
Ongoing monitoring and follow-up should include regular re-assessment of dietary intake and hydration, for example, using food logs and/or food photos, and re-assessment of nutrient levels, using clinically accepted methodologies, during therapy to identify and promptly address emerging deficiencies
Thinner needles cause less discomfort but draw medication more slowly
The breakdown products lactic acid and glycolic acid are subsequently eliminated from the body as carbon dioxide and water
El farmacutico enva la solicitud al programa puente, que la revisa